Monday, 16 October 2017

Aimmune teams with Regeneron, Sanofi on peanut allergy drug

(Reuters) - Aimmune Therapeutics Inc said on Monday it would collaborate with Regeneron Pharmaceuticals Inc and Sanofi to develop its experimental peanut allergy drug.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)